Stewart & Patten CO LLC Amgen Inc Transaction History

Stewart & Patten CO LLC

$664 Million
Q1 2024

A detailed history of Stewart & Patten CO LLC transactions in Amgen Inc stock. As of the latest transaction made, Stewart & Patten CO LLC holds 6,460 shares of AMGN stock, worth $1.9 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

6,460

Previous 6,460 -0.0%

Holding current value

$1.9 Million

Previous $1.86 Million 1.29%

% of portfolio

0.28%

Previous 0.29%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $102,280 - $115,383	-400 Reduced 5.83%	6,460 $1.86 Million
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $407,113 - $481,403	1,900 Added 38.31%	6,860 $1.52 Million
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $45,806 - $58,202	-200 Reduced 3.88%	4,960 $1.3 Million
Q3 2022 Oct 19, 2022	SELL	$224.46 - $253.15 $44,892 - $50,630	-200 Reduced 3.73%	5,160 $1.16 Million
Q2 2022 Jul 21, 2022	SELL	$230.71 - $256.74 $4,383 - $4,878	-19 Reduced 0.35%	5,360 $1.3 Million
Q1 2022 Apr 22, 2022	SELL	$219.27 - $242.57 $117,090 - $129,532	-534 Reduced 9.03%	5,379 $1.3 Million
Q3 2021 Oct 20, 2021	SELL	$212.27 - $248.7 $31,203 - $36,558	-147 Reduced 2.43%	5,913 $1.26 Million
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $186,864 - $207,312	-800 Reduced 11.66%	6,060 $1.48 Million
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $221,910 - $258,600	-1,000 Reduced 12.72%	6,860 $1.71 Million
Q4 2020 Jan 25, 2021	SELL	$216.38 - $257.67 $108,190 - $128,835	-500 Reduced 5.98%	7,860 $1.81 Million
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $586,625 - $652,375	-2,500 Reduced 23.02%	8,360 $2.13 Million
Q2 2020 Jul 17, 2020	SELL	$197.81 - $242.74 $98,905 - $121,370	-500 Reduced 4.4%	10,860 $2.56 Million
Q1 2020 Apr 16, 2020	SELL	$182.24 - $241.7 $91,120 - $120,850	-500 Reduced 4.22%	11,360 $2.3 Million
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $293,653 - $377,446	-1,552 Reduced 11.57%	11,860 $2.86 Million
Q3 2019 Oct 17, 2019	BUY	$174.11 - $208.62 $788,892 - $945,257	4,531 Added 51.02%	13,412 $2.6 Million
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $17,003 - $19,931	-102 Reduced 1.14%	8,881 $1.64 Million
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $19,895 - $22,426	-110 Reduced 1.21%	8,983 $1.71 Million
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $7,967 - $8,982	-43 Reduced 0.47%	9,093 $1.89 Million
Q2 2018 Jul 25, 2018	SELL	$166.05 - $186.51 $33,210 - $37,302	-200 Reduced 2.14%	9,136 $1.69 Million
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $240,251 - $280,764	-1,418 Reduced 13.19%	9,336 $1.59 Million
Q4 2017 Jan 29, 2018	SELL	$168.79 - $188.59 $164,907 - $184,252	-977 Reduced 8.33%	10,754 $1.87 Million
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $1.96 Million - $2.24 Million	11,731	11,731 $2.19 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stewart & Patten CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stewart & Patten CO LLC with notifications on news.

Account

Stewart & Patten CO LLC Amgen Inc Transaction History